Growth Assessment in Children Under 12 Years With Moderate-to-Severe Atopic Dermatitis Included in the…

Cross-sectionalPediatric dermatology· Aug 2026

Growth Assessment in Children Under 12 Years With Moderate-to-Severe Atopic Dermatitis Included in the PEDISTAD Observational Registry.

Amy S Paller, Alan D Irvine, Eulalia Baselga … Annie Zhang

Allergy & ImmunologyCross-sectionalQ2IF 1.1

Boys 5–12 with moderate-to-severe atopic dermatitis had lower height percentiles than peers

Growth Assessment in Children Under 12 Years With Moderate-to-Severe Atopic Dermatitis Included in the PEDISTAD Observational Registry.

Amy S Paller … Annie Zhang

Pediatric dermatology · Aug 2026 · Q2 in Pediatrics

Background

The multifactorial disease burden of moderate-to-severe atopic dermatitis (atopic dermatitis) may affect children's growth.

Methods

This was a cross-sectional analysis of enrollment data from PEDISTAD, a global real-world observational study of pediatric patients < 12 years old with moderate-to-severe atopic dermatitis.

n = 1329 children

Results

most boys with moderate to severe atopic dermatitis had below average height for age

Males below 50th perce

72%

Females below 50th per

53%

More results

In contrast, the weight of children 5 to < 12 years was above the 50th percentile in 56% of males and 52% of females, resulting in above-average BMI values.

In the 0 to < 5 years old age groups, height and weight were above the 50th percentile for 59% and 50% of female children, and 52% and 42% of male children, respectively.

“

Conclusion · 1 of 2

This real-world observational study showed in children 5 to < 12 years old with moderate-to-severe atopic dermatitis that the average height was lower than the US 50th percentile, with a more pronounced reduction in male children.

Conclusion · 2 of 2

Additionally, higher weight and, as a result, higher BMI were observed in the children included in this analysis.

Growth Assessment in Children Under 12 Years With Moderate-to-Severe Atopic Dermatitis Included in the PEDISTAD Observational Registry.

Growth Assessment in Children Under 12 Years With Moderate-to-Severe Atopic Dermatitis Included in the PEDISTAD Observational Registry.

Related papers